Novel Aspects of Hereditary Spastic Paraplegia: A Clinicopathologic and Biochemical Study of a Patient With a Heterozygous <i>GCH1</i> Variant

The authors declare no conflicts of interest. The datasets used and analysed during the present study are available from the corresponding author on reasonable request. Figure S1 Schematic diagram of the GCH1-related biosynthetic pathway. Figure S2 Neuropathological findings in the motor system and nigrostriatal system. Figure S3 GCH1 protein expression in the substantia nigra and putamen. Figure S4 Biochemical analysis of GCH1-related metabolites and monoamines in the putamen. Table S1 Primary antibodies. Table S2 Demographics and clinical features of previously reported patients with HSP-GCH1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Authors

Institutions

Publication Details

Journal
Neuropathology and Applied Neurobiology
Published
2025-02-01
DOI
https://doi.org/10.1111/nan.70006
Primary Topic
Hereditary Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Aspects of Hereditary Spastic Paraplegia: A Clinicopathologic and Biochemical Study of a Patient With a Heterozygous GCH1 Variant

Norikazu Hara, Akiyoshi Kakita, Hiroshi Ichinose, Tetsuo Ozawa et al.
Neuropathology and Applied Neurobiology
Hereditary Neurological Disorders
article

Novel Aspects of Hereditary Spastic Paraplegia: A Clinicopathologic and Biochemical Study of a Patient With a Heterozygous GCH1 Variant

Norikazu Hara, Akiyoshi Kakita, Hiroshi Ichinose, Tetsuo Ozawa, Mari Tada, Takeshi Ikeuchi, Takashi Nakajima, Rina Aida, Shoko Hongo, Osamu Onodera, Akinori Miyashita, Tetsuhiko Ikeda
article en

Abstract

The authors declare no conflicts of interest. The datasets used and analysed during the present study are available from the corresponding author on reasonable request. Figure S1 Schematic diagram of the GCH1-related biosynthetic pathway. Figure S2 Neuropathological findings in the motor system and nigrostriatal system. Figure S3 GCH1 protein expression in the substantia nigra and putamen. Figure S4 Biochemical analysis of GCH1-related metabolites and monoamines in the putamen. Table S1 Primary antibodies. Table S2 Demographics and clinical features of previously reported patients with HSP-GCH1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Neuropathology and Applied NeurobiologyVol. 51(1)
Nishi Niigata Chuo National Hospital (JP), Niigata University (JP)
Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science
Openalex Percentile: Top 96%
Hereditary Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.